Retatrutide Injection Temperature and Storage Guidelines
Storage Requirements
- Unopened retatrutide vials should be refrigerated at 2 – 8 °C (36 – 46 °F) and must never be frozen, because freezing can alter the drug’s molecular structure and reduce its efficacy【1】.
- Patients should confirm that their home refrigerator consistently maintains the 2 – 8 °C range, as many household units operate outside this optimal window【1】.
- The medication must be kept away from direct sunlight, heat sources, and excessive agitation during storage to preserve stability【1】.
Pre‑Injection Warming Protocol
- Retatrutide should be allowed to equilibrate to room temperature (approximately 15 – 30 °C or 59 – 86 °F) for 30–60 minutes before subcutaneous administration【2】.
- Warming the medication to ambient temperature markedly reduces injection‑related pain compared with injecting a cold solution【1】.
- Allowing the drug to reach room temperature also lowers the risk of lipodystrophy (abnormal fat distribution) at the injection site【2】.
- Molecular stability and absorption are optimized when the preparation is at ambient temperature, supporting consistent therapeutic effect【2】.
Injection Site Preparation and Safety Checks
- Prior to injection, the injection site must be clean and dry to minimize infection risk【1】.
- The solution should be visually inspected for any clumping, frosting, precipitation, or changes in clarity or color; any such abnormalities indicate that the product should not be used【2】.
- The expiration date must be verified; expired retatrutide should be discarded【2】.
Transportation Considerations
- When transporting retatrutide in hot or cold weather, insulated bags or cooler packs should be used to maintain the required 2 – 8 °C temperature range【2】.
- The time the medication spends outside of refrigeration should be minimized to preserve potency【2】.
- Upon arrival at the injection location, the vial should be returned promptly to refrigeration or, if injection is imminent, the 30–60 minute warming protocol should be initiated【2】.
Common Pitfalls to Avoid
- Direct heat sources (e.g., microwaves, hot water, heating pads) must never be employed to accelerate warming, as they can degrade the medication【2】.
- Frost‑free freezers should be avoided because temperature cycling can compromise drug integrity【1】.
- Storing retatrutide in refrigerator doors is discouraged due to temperature fluctuations caused by frequent opening and closing【1】.